Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IM Cannabis (IMCC) Accounts Payables (2019 - 2026)

IM Cannabis has reported Accounts Payables over the past 8 years, most recently at $6.0 million for Q1 2026.

  • For Q1 2026, Accounts Payables changed N/A year-over-year to $6.0 million; the TTM value through Mar 2026 reached $6.0 million, changed N/A, while the annual FY2025 figure was $8.6 million, 6.06% up from the prior year.
  • Accounts Payables was $6.0 million for Q1 2026 at IM Cannabis, down from $8.6 million in the prior quarter.
  • Across five years, Accounts Payables topped out at $11.3 million in Q4 2022 and bottomed at $1.2 million in Q2 2024.
  • The 5-year median for Accounts Payables is $7.4 million (2023), against an average of $7.0 million.
  • Year-over-year, Accounts Payables surged 204.67% in 2022 and then tumbled 39.94% in 2023.
  • Over 5 years, Accounts Payables stood at $11.3 million in 2022, then tumbled by 39.94% to $6.8 million in 2023, then rose by 17.91% to $8.0 million in 2024, then rose by 8.22% to $8.6 million in 2025, then tumbled by 30.8% to $6.0 million in 2026.
  • The last three reported values for Accounts Payables were $6.0 million (Q1 2026), $8.6 million (Q4 2025), and $8.0 million (Q4 2024) per Business Quant data.